A 28-year-old woman with heavy menstrual bleeding and iron-deficiency anemia. What is a long-term management option to reduce menses-related blood loss?

Prepare for the NBME Form 10 Step 2 Test. Utilize flashcards and multiple choice questions, with hints and explanations for each. Ace your exam preparation!

Multiple Choice

A 28-year-old woman with heavy menstrual bleeding and iron-deficiency anemia. What is a long-term management option to reduce menses-related blood loss?

Explanation:
The main idea is controlling heavy menstrual bleeding with a long-term approach that reduces cycle blood loss. Hormonal therapy does this by suppressing ovulation and thinning the endometrium, which greatly decreases how much bleeding occurs each month. Options like combined oral contraceptives or a levonorgestrel-releasing intrauterine device are effective for reducing menses, and they also help with iron-deficiency anemia by limiting ongoing blood loss. Iron supplementation is important to treat the existing anemia, but it doesn’t address the underlying heavy bleeding over time. NSAIDs can help modestly but aren’t as durable or impactful as hormonal options. Hysterectomy is a drastic step not appropriate for a young patient when less invasive, effective long-term therapies exist.

The main idea is controlling heavy menstrual bleeding with a long-term approach that reduces cycle blood loss. Hormonal therapy does this by suppressing ovulation and thinning the endometrium, which greatly decreases how much bleeding occurs each month. Options like combined oral contraceptives or a levonorgestrel-releasing intrauterine device are effective for reducing menses, and they also help with iron-deficiency anemia by limiting ongoing blood loss. Iron supplementation is important to treat the existing anemia, but it doesn’t address the underlying heavy bleeding over time. NSAIDs can help modestly but aren’t as durable or impactful as hormonal options. Hysterectomy is a drastic step not appropriate for a young patient when less invasive, effective long-term therapies exist.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy